» Articles » PMID: 25418549

Can Metabolically Healthy Obesity Be Explained by Diet, Genetics, and Inflammation?

Overview
Date 2014 Nov 25
PMID 25418549
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

A substantial proportion of obese individuals do not present cardiometabolic complications such as diabetes, hypertension, or dyslipidemia. Some, but not all, prospective studies observe similar risk of cardiovascular events and all-cause mortality among individuals with this so-called "metabolically healthy obese" (MHO) phenotype, compared to the metabolically healthy normal weight or metabolically healthy non-obese phenotypes. Compared to the metabolically unhealthy obese (MUO) phenotype, MHO is often characterized by a more favorable inflammatory profile, less visceral fat, less infiltration of macrophages into adipose tissue, and smaller adipocyte cell size. Tipping the inflammation balance in adipose tissue might be particularly important for metabolic health in the obese. While the potential role of genetic predisposition or lifestyle factors such as diet in the MHO phenotype is yet to be clarified, it is well known that diet affects inflammation profile and contributes to the functionality of adipose tissue. This review will discuss genetic predisposition and the molecular mechanisms underlying the potential effect of food on the development of the metabolic phenotype characteristic of obesity.

Citing Articles

Associations Between Body Mass Index (BMI) and Dyslipidemia: Results From the PERSIAN Guilan Cohort Study (PGCS).

Shahraz J, Joukar F, Sheida F, Yeganeh S, Maroufizadeh S, Baghaee M Obes Sci Pract. 2025; 11(1):e70055.

PMID: 39917550 PMC: 11802237. DOI: 10.1002/osp4.70055.


Systemic Inflammation Across Metabolic Obesity Phenotypes: A Cross-Sectional Study of Korean Adults Using High-Sensitivity C-Reactive Protein as a Biomarker.

Baek S, Yoon J Int J Mol Sci. 2024; 25(21).

PMID: 39519093 PMC: 11547168. DOI: 10.3390/ijms252111540.


Mediterranean Lifestyle: More Than a Diet, A Way of Living (and Thriving).

Kushkestani M, Moghadassi M, Sidossis L Endocr Metab Immune Disord Drug Targets. 2024; 24(15):1785-1793.

PMID: 38424420 DOI: 10.2174/0118715303279769240215105510.


Lipid Peroxidation as a Possible Factor Affecting Bone Resorption in Obese Subjects-Preliminary Research.

Maciejewski M, Siodmiak J, Borkowski B, Lorkowski M, Olszewska-Slonina D Int J Mol Sci. 2023; 24(14).

PMID: 37511388 PMC: 10380302. DOI: 10.3390/ijms241411629.


Inflammatory cytokines and chemokines in obese adolescents with antibody against to adenovirus 36.

Sanches M, Goldberg T, Rizzo A, da Silva V, Mosca L, Romagnoli G Sci Rep. 2023; 13(1):9918.

PMID: 37336969 PMC: 10279706. DOI: 10.1038/s41598-023-33084-4.